Eskander Elhamy MD is categorized under Internal Medicine Doctors in Frederick, MD and active since 1976.
Eskander Elhamy MD was established in 1976, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Elhamy Eskander at the company’s single location by writing to 501 West 7th St # 1, Frederick, Maryland MD 21701 or by phoning (301) 662-8477. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Eskander Elhamy MD |
| Contact Person: | Elhamy Eskander |
| Address: | 501 West 7th St # 1, Frederick, Maryland 21701 |
| Phone Number: | (301) 662-8477 |
| Website Address: | cancercarefrederick.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1976 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Eskander Elhamy MD was started in 1976 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Elhamy Eskander for inquiries that concern Eskander Elhamy MD by calling the company number (301) 662-8477, as your correspondence is most welcome. Additionally, the physical location of the single location of Eskander Elhamy MD can be found at the coordinates 39.42495,-77.41568 as well as the street address 501 West 7th St # 1 in Frederick, Maryland 21701.
For its online presence, you may visit Eskander Elhamy MD’s website at cancercarefrederick.com and engage with its social media outlets through on Twitter and on Facebook.